MHRA: Field Safety Notices Issued, 17-21 August 2026

• The MHRA issued several Field Safety Notices (FSNs) between August 17 and 21, 2026, concerning various medical devices.
• Recipients of manufacturer-issued FSNs are legally required to act on the instructions provided.
• Notices included a handheld fibre-optic device for nasogastric tube placement, circulating-fluid thermal/compression therapy equipment, and specific models of single-use vaginal speculums.
• The MHRA publishes these FSNs for information, directing specific inquiries to the device manufacturers.
• Historical FSN data is available from January 2020, November 2014, and via the National Archives for earlier records.

Recipients of a Field Safety Notice directly from a manufacturer are under a strict obligation to take immediate action as specified within the notice.

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a series of Field Safety Notices (FSNs) concerning various medical devices, covering the period from August 17 to August 21, 2026. These notices serve as critical alerts for potential issues with devices available on the market in Great Britain. While the MHRA publishes these FSNs primarily for informational purposes, they carry significant weight for all stakeholders in the healthcare supply chain.

Recipients of a Field Safety Notice directly from a manufacturer are under a strict obligation to take immediate action as specified within the notice. This mandatory compliance ensures that any identified risks associated with medical devices are promptly addressed, safeguarding patient well-being and maintaining product integrity across the UK medical device landscape.

Among the alerts issued during this five-day window, several specific devices were highlighted. One notice, identified by MHRA reference 40608329 and FSN number 2026/008/004/601/081, pertains to a handheld fibre-optic device. This particular instrument is designed to assist healthcare professionals in the accurate placement of nasogastric feeding tubes, indicating a potential concern in a critical patient care procedure.

Another significant alert, MHRA reference 40555952 with FSN number 2026/008/006/601/181, addresses circulating-fluid thermal/compression therapy equipment. Furthermore, the MHRA has issued an FSN (reference 40553184, number 2026/008/014/601/126) for specific models of single-use vaginal speculums. The affected models include KJ-V01-XS, KJ-V01-S, KJV01-M, KJ-V01-ML, and KJ-V01-L, indicating a broad scope within this product category. Additional FSNs were also released during this period, including those with MHRA references 40571590, 40569724 (FSN 2026/008/018/601/099), 40550459 (FSN 2026/008/017/601/146), and 40568323 (FSN 2026/007/016/601/148), though specific device details for these were not provided in the immediate listing.

The MHRA plays a crucial role in overseeing the safety and performance of medical devices within the United Kingdom. Its publication of FSNs is a key mechanism for disseminating vital safety information to the healthcare sector. While the agency provides these lists for general awareness, any detailed inquiries regarding a specific notice should be directed to the issuing manufacturer, who holds the primary responsibility for the device and its associated safety actions.

For those needing to consult historical data, the MHRA maintains an accessible archive of FSNs. Records are available for notices published since January 2020, with further listings extending back to November 2014. For Field Safety Notices issued prior to November 2014, the comprehensive records can be found on the National Archives website, ensuring a complete historical overview of UK medical device safety alerts.

These recent GB medical device recalls and safety alerts underscore the continuous need for vigilance within the medical device industry. For legal professionals and compliance officers advising manufacturers, distributors, or healthcare providers in the UK, a thorough review of these MHRA Field Safety Notices is essential. It ensures that clients are fully aware of and can promptly comply with any mandatory actions stipulated for affected devices.

Proactive engagement with these notices is not merely a regulatory formality; it is a critical step in mitigating potential legal liability and, most importantly, in upholding the highest standards of patient safety. The requirement to act on FSNs from manufacturers forms a cornerstone of the UK's medical device safety framework, demanding diligent attention from all parties involved.

Lawyers and compliance officers advising medical device manufacturers, distributors, or healthcare providers in the UK must review these MHRA Field Safety Notices to ensure their clients are aware of and comply with mandatory actions regarding affected devices, mitigating potential liability and ensuring patient safety.

Source: Original reporting via GOV.UK